Atomistry » Magnesium » PDB 4nb4-4nln » 4neu
Atomistry »
  Magnesium »
    PDB 4nb4-4nln »
      4neu »

Magnesium in PDB 4neu: X-Ray Structure of Receptor Interacting Protein 1 (RIP1)Kinase Domain with A 1-Aminoisoquinoline Inhibitor

Enzymatic activity of X-Ray Structure of Receptor Interacting Protein 1 (RIP1)Kinase Domain with A 1-Aminoisoquinoline Inhibitor

All present enzymatic activity of X-Ray Structure of Receptor Interacting Protein 1 (RIP1)Kinase Domain with A 1-Aminoisoquinoline Inhibitor:
2.7.11.1;

Protein crystallography data

The structure of X-Ray Structure of Receptor Interacting Protein 1 (RIP1)Kinase Domain with A 1-Aminoisoquinoline Inhibitor, PDB code: 4neu was solved by R.T.Nolte, P.Ward, K.M.Kahler, N.Campobasso, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 47.94 / 2.57
Space group H 3 2
Cell size a, b, c (Å), α, β, γ (°) 149.249, 149.249, 187.670, 90.00, 90.00, 120.00
R / Rfree (%) 18.1 / 23.5

Magnesium Binding Sites:

The binding sites of Magnesium atom in the X-Ray Structure of Receptor Interacting Protein 1 (RIP1)Kinase Domain with A 1-Aminoisoquinoline Inhibitor (pdb code 4neu). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the X-Ray Structure of Receptor Interacting Protein 1 (RIP1)Kinase Domain with A 1-Aminoisoquinoline Inhibitor, PDB code: 4neu:

Magnesium binding site 1 out of 1 in 4neu

Go back to Magnesium Binding Sites List in 4neu
Magnesium binding site 1 out of 1 in the X-Ray Structure of Receptor Interacting Protein 1 (RIP1)Kinase Domain with A 1-Aminoisoquinoline Inhibitor


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of X-Ray Structure of Receptor Interacting Protein 1 (RIP1)Kinase Domain with A 1-Aminoisoquinoline Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg401

b:46.2
occ:0.50
 O A:PHE17 2.0 54.2 1.0
O A:SER14 2.4 64.0 1.0
C A:PHE17 3.2 51.9 1.0
C A:SER14 3.6 65.2 1.0
CA A:LEU18 3.7 51.9 1.0
N A:LEU18 3.9 51.0 1.0
CB A:LEU18 4.3 52.3 1.0
CA A:SER14 4.3 66.9 1.0
CA A:PHE17 4.4 51.8 1.0
N A:PHE17 4.4 53.8 1.0
CD2 A:PHE17 4.6 48.6 1.0
CB A:SER14 4.6 70.0 1.0
N A:SER15 4.6 65.1 1.0
CG A:PHE17 4.7 50.0 1.0
CE2 A:PHE17 4.8 48.8 1.0
CA A:SER15 4.8 65.0 1.0
C A:LEU18 4.9 50.5 1.0
CD1 A:PHE17 5.0 51.3 1.0

Reference:

P.A.Harris, D.Bandyopadhyay, S.B.Berger, N.Campobasso, C.A.Capriotti, J.A.Cox, L.Dare, J.N.Finger, S.J.Hoffman, K.M.Kahler, R.Lehr, J.D.Lich, R.Nagilla, R.T.Nolte, M.T.Ouellette, C.S.Pao, M.C.Schaeffer, A.Smallwood, H.H.Sun, B.A.Swift, R.D.Totoritis, P.Ward, R.W.Marquis, J.Bertin, P.J.Gough. Discovery of Small Molecule RIP1 Kinase Inhibitors For the Treatment of Pathologies Associated with Necroptosis. Acs Med Chem Lett V. 4 1238 2013.
PubMed: 24900635
DOI: 10.1021/ML400382P
Page generated: Mon Aug 19 23:32:26 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy